Results 101 to 110 of about 1,314 (191)

Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant – A Case Report

Ophthalmology and Therapy, 2019
In January 2013, a 54-year-old pseudophakic woman was referred to the ocular inflammation clinic with a diagnosis of panuveitis, already on oral cyclosporine (100 mg/day) since 2010.
Jorge Meira, Carolina Madeira, Fernando Falcão-Reis, Luís Figueira   +3 more
doaj   +1 more source

Use of flucinolone acetonide for patients with diabetic macular oedema:patient selection criteria and early outcomes in real world setting [PDF]

, 2016
Introduction: Fluocinolone acetonide slow release implant (Iluvien®) was approved in December 2013 in UK for treatment of eyes which are pseudophakic with DMO that is unresponsive to other available therapies.
Ajay Bhatnagar, Andrej Kidess, CS Brand, D Boyer, DM Brown, DS Boyer, DS Levin, E Chew, Fahad Quhill, Ibrahim Elaraoud, JA Wells, JW Yau, Marie Tsaloumas, MJ Elman, NZ Gregori, PA Campochiaro, PA1 Campochiaro, Walter Andreatta, Yit Yang   +18 more
core   +1 more source

Behandlung des diabetischen Makulaödems mit einem Fluocinolonacetonid-Implantat (Iluvien®): Monozentrische „real life“-Langzeitdaten

, 2018
26.
Duncker, T, Prinke, MM
openaire   +2 more sources

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]

Clinical Ophthalmology, 2020
Kasserine Taylor,1 Michael W Stewart2 1Department of Ophthalmology, Mayo Clinic Florida, Jacksonville, FL, USA; 2Cornell University, Ithaca, NY, USACorrespondence: Michael W StewartDepartment of Ophthalmology, Mayo Clinic Florida, 4500 San Pablo Road ...
Taylor K, Stewart MW
doaj  

Sustained Release Intraocular Drug Delivery Devices for Treatment of Uveitis [PDF]

, 2011
Corticosteroids have been the mainstay of uveitis therapy. When intraocular inflammation is unresponsive to steroids, or steroid related side effects become a concern, steroid-sparing medications may be administered which can be classified into ...
Abdekhodaie, Mohammad Jafar, Haghjou, Nahid, Soheilian, Masoud   +2 more
core   +2 more sources

Erste Erfahrungen mit Fluocinolonacetonid (Iluvien) in der Behandlung des diabetischen Makulaödems (K)

, 2015
28.
Hornischer, C, Jochmann, C, Wiedemann, P
openaire   +2 more sources

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature

Clinical Ophthalmology, 2017
Habiba Saedon,1 Astha Anand,1 Yit C Yang1,2 1Department of Ophthalmology, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, 2School of Life and Health Sciences, Aston University, Birmingham, UK Abstract: The first-line therapy for patients ...
Saedon H, Anand A, Yang YC
doaj  

Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema

Journal of Ophthalmic Inflammation and Infection, 2019
Background A retrospective observational clinical study to evaluate the safety and effectiveness of the injectable 0.19-mg fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema.
Lea F. Weber, Stefanie Marx, Gerd U. Auffarth, Alexander F. Scheuerle, Tamer Tandogan, Christian Mayer, Ramin Khoramnia   +6 more
doaj   +1 more source

Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials

Current Medical Research and Opinion, 2019
Objective: To compare the effectiveness and safety of the fluocinolone acetonide (FAc) intravitreal implant between the observational Iluvien Clinical Evidence study in the United Kingdom (ICE-UK) and the Fluocinolone Acetonide in Diabetic Macular Edema (
S. Holden, B. Kapik, A. Beiderbeck, C. Currie   +3 more
semanticscholar   +1 more source

Treatment of refractory diabetic macular edema with a fluocinolone acetonide implant in vitrectomized and non-vitrectomized eyes [PDF]

, 2018
AIM: To report real-life data on the use of an intravitreal fluocinolone acetonide implant in the treatment of refractory diabetic macular edema (DME) in pars plana vitrectomized (PPV) and non-PPV eyes.
Alan Hawrami, Alberto La Mantia, Hadi Zambarakji, Heidi Laviers, Sudeshna Patra   +4 more
core   +1 more source